The new funding of $80 Million will give Tempus Company and Eric Lefkofsky the attribute called 'Unicorn' Status in Chicago.
The Company was founded in 2015 and it has 400 employees and it is expanding every day with more than 30 people being hired every month.
The Co-Founder and CEO of Tempus a Company with advanced technology and an operating system has received 210 Million in investments until now.
The Electronic and Medical Record (EMR)and Pathology are not getting sufficient data to help them find the best treatment for every patient.
Therefore, Tempus is helping with results collecting data from patients undergoing the treatment of Cancer. Eric Lefkofsky and Tempus are getting in a relationship with drug companies and the healthcare
